Featuring CEO Interview with Francois Nader, MD, Chairman, Acceleron Pharma Inc.
Volume 3, Number 5
Whether you are or you require executive or management talent — interim, permanent, or interim to hire — Ashton Tweed can meet your specialized retained search and executive search needs.
CEO Leadership Series: Francois Nader, MD, Chairman, Acceleron Pharma Inc.
Dr. Francois Nader knows something about the importance of embracing culture, whether it’s on a personal or professional level. He earned a medical degree in Beirut and has worked in France, Canada, Kansas City, Mo. and New Jersey. Dr. Nader has also directed the complete turnaround of a struggling biopharma company – starting with the organization’s culture.
Interim BD & Oncology Expert Helps Rebrand Company
A biotechnology company with a unique technology platform was looking to reposition and rebrand itself as a delivery platform company in the oncology space. With this corporate reset of priorities, the company needed assistance in executing these changes in the form of an Interim Vice President of Business Development…
It’s hard to make time for networking within your already busy work schedule, but it’s important not to let your networking efforts slack. There’s no need to make networking an impossible chore or burden. If you don’t have the time to participate in networking events and conferences regularly, it’s wise to break up your networking agenda into…
Subscribe Today for Ashton Tweed’s Weekly Digest Emails that cover hiring, firing, and retiring news in the Life sciences industry. Click below to STay in the loop:
The top companies in med tech: 2015 revenue results
FierceMedicalDevices’ 2015 med tech top revenues list is based on medical device and diagnostics sales data provided by Evaluate Medtech. The only sizable sales increases last year were driven by major acquisitions, and only two companies had sales growth without an acquisition. See the list…
CRISPR gene-editing approved for first human trials
A federal ethics and biosafety panel has approved the first human trials using CRISPR-Cas9. Researchers at UPenn will remove immune system T cells from up to 15 patients with multiple melanoma, melanoma, and sarcoma. The cells will be modified to fight malignant cells normally, then reinserted into…
Brexit means EMA must find a new home, and so much more
The European Medicines Agency (EMA) is headquartered in London, but since the U.K. voted to leave the European Union, the EMA will now have to find a new home, even though it just moved into its new building two years ago. It is one of many concerns that affect the pharma industry due to Britain’s historic vote…
Starting this July, over 50 pharmaceutical companies in Switzerland will reveal how much they pay for health services and consultations. This European Federation of Pharmaceutical Industries and Associations’ initiative hopes to increase transparency and reinforce public confidence in the pharmaceutical and health…
Top 10 Biotech Jobs Most in Demand over the Next Decade
This is a list of the top 10 research and clinical biotech professions projected to add jobs through 2024, according to the U.S. Bureau of Labor Statistics’2016-17Occupational Outlook Handbook. The positions areranked by the number of expected jobs to be created between 2014 and 2024…
VA teams with IBM’s supercomputer Watson to expand precision medicine
IBM partners with the US Department of Veterans Affairs to analyze genomic data of 10,000 cancer patients and expand the agency’s precision oncology program. This collaboration is a byproduct of Vice President Joe Biden’s Cancer Moonshot efforts….
Venture-Backed Biotech Companies Lead Charge to Public Markets
Twelve venture-backed initial public offerings raised $893.9M in the second quarter of 2016, according to the Exit Poll Report by Thomson Reuters and the National Venture Capital Association. Led by biotechnology companies, nine of this quarter’s…
